Health Care
Commentary
Read the latest on the problems facing Medicare
Medicare Is Now Unaffordable
“If anyone here tries to cut … Medicare … I will stop you.” That was President Biden’s promise to a joint session of Congress during last week’s State of the Union address. Some may find such tough talk reassuring. But Biden’s refusal to even acknowledge Medicare’s dire fiscal situation — much less chart a course ...
Commentary
Read about the latest drug rationing proposals
Let UK Keep Drug Rationing
Any list of the world’s most inhumane healthcare bureaucracies has to include Britain’s National Institute for Health and Care Excellence at the top. For over two decades, the agency has employed ruthless cost-benefit analyses to effectively deny British patients access to the latest medicines. Now NICE is looking to export its expertise rationing ...
Commentary
Medicaid shouldn’t pay for housing
Massachusetts is asking the Biden administration for permission to use money from Medicaid, the health program for low-income and disabled Americans jointly funded by the states and the federal government, to pay for temporary housing for homeless families and pregnant women, including newly arrived immigrants. It’s only the latest request by states to spend money specifically earmarked ...
Blog
Spending Watch
Single Payer Will Worsen California’s Healthcare System and Reduce Economic Growth
Single Payer Will Worsen California’s Healthcare System and Reduce Economic Growth Wayne Winegarden March 2024 With the introduction of AB 2200, advocates are, once again, proposing that California adopt a single payer healthcare system. Ostensibly, their proposed CalCare system would streamline payments, lower per-capita spending, guarantee “quality health care and ...
Commentary
Bane of High Health Care Costs Can Be Traced to Obamacare
About 3 in 4 Americans are at least somewhat worried about their ability to afford health care, according to the KFF Health Tracking Poll February 2024. That concern is at odds with their generally favorable view of the Affordable Care Act, which will mark its 14th birthday on March 23. Nearly 6 in ...
Coronavirus
NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Commentary
Read the latest on medicare spending
Competition Or Insolvency? Medicare’s Time For Choosing.
America has a spending problem. Last month, the Congressional Budget Office reported that debt held by the public will exceed the entire economic output of the country next year. Within ten years, the debt will reach 116% of GDP—”an amount greater than at any point in the nation’s history,” as the ...
Commentary
Don’t take away short-term health plans
The Biden administration may soon finalize rules that would deprive many Americans, especially young and healthy ones, of affordable insurance coverage. That will be the consequence of President Joe Biden‘s plan to reverse a 2018 rule promulgated by the Trump administration that allowed low-cost short-term health plans to last up ...
Commentary
Obamacare coverage might be free. But that’s not good.
There’s a saying that nothing good in life is free. The latest Obamacare enrollment numbers are a case in point. The Biden administration recently announced that a record 21.3 million Americans signed up for Obamacare during this year’s open enrollment period. But many of those enrollees only signed up because they ...
Commentary
Read the latest on Senator Sanders' fight against major pharmaceutical firms
Sanders Won’t Let Facts Get In Way of a Good Pharma Shaming
Vermont Senator Bernie Sanders called the CEOs of several major pharmaceutical firms to testify earlier this month before the Senate Health, Education, Labor and Pensions Committee, where he serves as chairman. The hearing’s official purpose was to discuss prescription drug pricing. But it mainly offered Sanders a forum to castigate the pharmaceutical ...
Read the latest on the problems facing Medicare
Medicare Is Now Unaffordable
“If anyone here tries to cut … Medicare … I will stop you.” That was President Biden’s promise to a joint session of Congress during last week’s State of the Union address. Some may find such tough talk reassuring. But Biden’s refusal to even acknowledge Medicare’s dire fiscal situation — much less chart a course ...
Read about the latest drug rationing proposals
Let UK Keep Drug Rationing
Any list of the world’s most inhumane healthcare bureaucracies has to include Britain’s National Institute for Health and Care Excellence at the top. For over two decades, the agency has employed ruthless cost-benefit analyses to effectively deny British patients access to the latest medicines. Now NICE is looking to export its expertise rationing ...
Medicaid shouldn’t pay for housing
Massachusetts is asking the Biden administration for permission to use money from Medicaid, the health program for low-income and disabled Americans jointly funded by the states and the federal government, to pay for temporary housing for homeless families and pregnant women, including newly arrived immigrants. It’s only the latest request by states to spend money specifically earmarked ...
Spending Watch
Single Payer Will Worsen California’s Healthcare System and Reduce Economic Growth
Single Payer Will Worsen California’s Healthcare System and Reduce Economic Growth Wayne Winegarden March 2024 With the introduction of AB 2200, advocates are, once again, proposing that California adopt a single payer healthcare system. Ostensibly, their proposed CalCare system would streamline payments, lower per-capita spending, guarantee “quality health care and ...
Bane of High Health Care Costs Can Be Traced to Obamacare
About 3 in 4 Americans are at least somewhat worried about their ability to afford health care, according to the KFF Health Tracking Poll February 2024. That concern is at odds with their generally favorable view of the Affordable Care Act, which will mark its 14th birthday on March 23. Nearly 6 in ...
NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Read the latest on medicare spending
Competition Or Insolvency? Medicare’s Time For Choosing.
America has a spending problem. Last month, the Congressional Budget Office reported that debt held by the public will exceed the entire economic output of the country next year. Within ten years, the debt will reach 116% of GDP—”an amount greater than at any point in the nation’s history,” as the ...
Don’t take away short-term health plans
The Biden administration may soon finalize rules that would deprive many Americans, especially young and healthy ones, of affordable insurance coverage. That will be the consequence of President Joe Biden‘s plan to reverse a 2018 rule promulgated by the Trump administration that allowed low-cost short-term health plans to last up ...
Obamacare coverage might be free. But that’s not good.
There’s a saying that nothing good in life is free. The latest Obamacare enrollment numbers are a case in point. The Biden administration recently announced that a record 21.3 million Americans signed up for Obamacare during this year’s open enrollment period. But many of those enrollees only signed up because they ...
Read the latest on Senator Sanders' fight against major pharmaceutical firms
Sanders Won’t Let Facts Get In Way of a Good Pharma Shaming
Vermont Senator Bernie Sanders called the CEOs of several major pharmaceutical firms to testify earlier this month before the Senate Health, Education, Labor and Pensions Committee, where he serves as chairman. The hearing’s official purpose was to discuss prescription drug pricing. But it mainly offered Sanders a forum to castigate the pharmaceutical ...
